CU Medical Systems, Inc.
Financials
Valuation Metrics
CU Medical Systems, Inc.'s Market Cap is ₩223B. At end of 2025 it was ₩333B. Ranked #2249 of 2,436 in KR market (top 92%), #1478 of 1,649 on KOSDAQ (top 90%), #94 of 96 in Health Care Equipment & Services (top 98%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 22.33B KRW | KR#2,249/2,436 Sec#94/96 |
| Revenue | 54.66B KRW | KR#1,732/2,436 Sec#49/96 |
| Net Income | 2.98B KRW | KR#1,270/2,436 Sec#41/96 |
| Total Assets | 134.45B KRW | KR#1,545/2,436 Sec#47/96 |
| Net Assets | 73.79B KRW | KR#1,613/2,436 Sec#49/96 |
| Employees | 120 | KR#1,495/2,436 Sec#51/96 |
| Value | ||
| P/E | 7.49x | KR#520/2,436 Sec#10/96 |
| P/B | 0.30x | KR#334/2,436 Sec#4/96 |
| PEG | 0.02x | KR#141/2,436 Sec#3/96 |
| P/S | 0.41x | KR#780/2,436 Sec#5/96 |
| EV/EBITDA | 3.73x | KR#127/2,436 Sec#4/96 |
| FCF Yield | 40.95% | KR#121/2,436 Sec#2/96 |
| Profitability | ||
| ROE | 4.04% | KR#1,110/2,436 Sec#38/96 |
| ROA | 2.22% | KR#1,096/2,436 Sec#43/96 |
| Op. Margin | 22.31% | KR#118/2,436 Sec#9/96 |
| Revenue Growth | 73.12% | KR#188/2,436 Sec#7/96 |
| Earnings Growth | 344.93% | KR#158/2,436 Sec#6/96 |
| Financial Health | ||
| Debt Ratio | 182.21% | KR#1,555/2,436 Sec#76/96 |
| Total Debt | 45.80B KRW | KR#1,018/2,436 Sec#26/96 |
| FCF | 9.15B KRW | KR#730/2,436 Sec#18/96 |
| Cash | 22.63B KRW | KR#1,165/2,436 Sec#30/96 |
| Current Ratio | 1.95x | KR#982/2,436 Sec#52/96 |
| Net Debt/EBITDA | 1.90x | KR#882/2,436 Sec#35/96 |
| Performance | ||
| 1Y Return | -39.01% | KR#1,814/2,436 Sec#64/96 |
| 1M Return | -3.26% | KR#1,233/2,436 Sec#54/96 |
| From 52W High | -44.35% | KR#948/2,436 Sec#37/96 |
| 1Y MDD | -47.05% | KR#793/2,436 Sec#24/96 |
| Trading | ||
| Volume | 12,748 shares | KR#2,051/2,436 Sec#85/96 |
| Foreign Own. | 1.69% | KR—/2,436 Sec—/96 |
| Per Share | ||
| EPS | 263 KRW | KR#1,128/2,436 Sec#35/96 |
| BPS | 5,134 KRW | KR#1,417/2,436 Sec#37/96 |
Company Info
CU Medical, established in 2001 and headquartered in Wonju-si, Gangwon-do, listed on KOSDAQ in 2011. The company specializes in developing, manufacturing, and selling medical devices, notably being the first in Asia to develop and market defibrillators. It offers a comprehensive product range, from general-use to hospital-specific devices, and is launching new Automated External Defibrillator (AED) products with world-first IP66 and IP68 ratings. With local subsidiaries in Germany and Japan, CU Medical implements tailored sales strategies for global markets.